Small molecule · Inhibitor of prostaglandin-endoperoxide synthase (cyclooxygenase) (PTGS2) · developed by Zyla Life Sciences
ApprovedFDA, Jun 1965
1Registered trials
What is Indomethacin?
Indomethacin is a small-molecule drug that inhibits prostaglandin synthesis. It is used to close a patent ductus arteriosus in premature infants, and it is also studied in acute gout.
Summary written with AI from the sources listed at the end of this page.
From the indications section of the FDA label (version of Jun 16, 2023). Read the full label for the exact wording, limitations and safety information.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.